Screening of plants with antimicrobial activity against enterobacteria, Pseudomonas spp. and Staphylococcus spp
Aim: This study screened plants for antibacterial properties against bacteria of medical importance. Materials & methods: 60 extracts were obtained from the leaves of ten plants ( Jatropha weddelliana, Attalea phalerata, Buchenavia tomentosa, Croton doctoris, Mouriri elliptica, Mascagnia benthamiana, Senna aculeata, Unonopis guatterioides, Allagoptera leucocalyx and Bactris glaucescens ) using different extraction methods: A) Ethanol 70°C/72 h; B) Water/5 min/100°C; C) Water/1 h/55°C; D) Water/72 h; E) Hexane/72 h and F) Ethanol 99°C/72 h. Enterobacteria/ Pseudomonas and staphylococci reference strains and 201 clinical isolates were used. Primary screening was done using agar well-diffusion assay. MIC/minimum bactericidal concentration and chemical characterization were determined. Results: Extracts 5F and 3A showed the best MIC/minimum bactericidal concentration against clinical isolates and showed the presence of phenols. Conclusion: The present study demonstrated that Mouriri elliptica and Buchenavia tomentosa were the most active plants against the studied bacteria..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Future microbiology - 12(2017), 8, Seite 671-681 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Girondi, Camila Miorelli [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biological products |
|---|
| doi: |
10.2217/fmb-2016-0129 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1995568503 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1995568503 | ||
| 003 | DE-627 | ||
| 005 | 20230517050101.0 | ||
| 007 | tu | ||
| 008 | 170721s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.2217/fmb-2016-0129 |2 doi | |
| 028 | 5 | 2 | |a PQ20170721 |
| 035 | |a (DE-627)OLC1995568503 | ||
| 035 | |a (DE-599)GBVOLC1995568503 | ||
| 035 | |a (PRQ)futurescience_futuremedicine_10_2217_fmb_2016_01290 | ||
| 035 | |a (KEY)0599475620170000012000800671screeningofplantswithantimicrobialactivityagainste | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q ZDB |
| 100 | 1 | |a Girondi, Camila Miorelli |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Screening of plants with antimicrobial activity against enterobacteria, Pseudomonas spp. and Staphylococcus spp |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Aim: This study screened plants for antibacterial properties against bacteria of medical importance. Materials & methods: 60 extracts were obtained from the leaves of ten plants ( Jatropha weddelliana, Attalea phalerata, Buchenavia tomentosa, Croton doctoris, Mouriri elliptica, Mascagnia benthamiana, Senna aculeata, Unonopis guatterioides, Allagoptera leucocalyx and Bactris glaucescens ) using different extraction methods: A) Ethanol 70°C/72 h; B) Water/5 min/100°C; C) Water/1 h/55°C; D) Water/72 h; E) Hexane/72 h and F) Ethanol 99°C/72 h. Enterobacteria/ Pseudomonas and staphylococci reference strains and 201 clinical isolates were used. Primary screening was done using agar well-diffusion assay. MIC/minimum bactericidal concentration and chemical characterization were determined. Results: Extracts 5F and 3A showed the best MIC/minimum bactericidal concentration against clinical isolates and showed the presence of phenols. Conclusion: The present study demonstrated that Mouriri elliptica and Buchenavia tomentosa were the most active plants against the studied bacteria. | ||
| 650 | 4 | |a Enterobacteria | |
| 650 | 4 | |a Staphylococcus | |
| 650 | 4 | |a spp | |
| 650 | 4 | |a Pseudomonas | |
| 650 | 4 | |a biological products | |
| 700 | 1 | |a de Oliveira, Analu Barros |4 oth | |
| 700 | 1 | |a Prado, Jackeline Alves |4 oth | |
| 700 | 1 | |a Koga-Ito, Cristiane Yumi |4 oth | |
| 700 | 1 | |a Borges, Aline Chiodi |4 oth | |
| 700 | 1 | |a Botazzo Delbem, Alberto Carlos |4 oth | |
| 700 | 1 | |a Alves Pereira, Daniel Freitas |4 oth | |
| 700 | 1 | |a Salvador, Marcos José |4 oth | |
| 700 | 1 | |a Brighenti, Fernanda Lourenção |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Future microbiology |d London : Future Medicine Ltd, 2006 |g 12(2017), 8, Seite 671-681 |w (DE-627)525875441 |w (DE-600)2273821-6 |x 1746-0913 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2017 |g number:8 |g pages:671-681 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.2217/fmb-2016-0129 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2017 |e 8 |h 671-681 | ||